Article

Artist's Balancing Act Inspires New York's Hope Murals Project

New York artist and GIST survivor, Ellen Mayer, painted "Balancing Act" to describe how she felt about her cancer experience. The artwork was later selected as one of 10 pieces to be publicly painted for The Hope Murals Project.

New York artist and gastrointestinal stromal tumors survivor, Ellen Mayer, painted "Balancing Act" in 2010 to help describe how she felt about her cancer experience and survivorship, including the constant need to balance emotions that come with it.

"I felt like I was constantly balancing in my head: Is it going to come back, is it not going to come back? That’s what this represents," she says. "All these little people represent life, and everybody in life, whether it’s cancer or anything else you’re going through, there is a point where you have to say 'OK, this is what it is and this is how I’m going to get back to balance.'"

After submitting the piece in 2010 for the Lilly Oncology on Canvas art competition, the organizers called Mayer this year to let her know that her "Balancing Act" was selected to be a part of the 10th anniversary of the competition. Mayer's original piece was made into nine large interlocking pieces, which were painted individually by the public on Oct. 23 in New York's Grand Central Terminal as part of The Hope Murals Project.

[Oncology on Canvas and The Hope Murals Project Reaches New York City]

The Hope Murals Project allows anyone who has been impacted by cancer, including patients, survivors and caregivers, to help paint a series of 10 murals around the country.

Related Videos
Photo credit: Max Mumby/Indigo via Getty Images
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Dr. Stephanie Alice Baker
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
Dr. Richard “Rick" Winneker
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
Related Content